SARS-CoV-2, Respiratory Syncytial Virus, and Influenza A/B Antigen Combined Detection Kit (Colloidal Gold)

For in vitro qualitative detection of SARS-CoV-2, respiratory syncytial virus, and influenza A/B antigens to aid in the differential diagnosis of COVID-19, RSV, and influenza infections.

SKU Code
AENE-RT152
Approval
On request
Product Type
Assay / Kit
Status
Available

For in vitro qualitative detection of SARS-CoV-2, respiratory syncytial virus, and influenza A/B antigens to aid in the differential diagnosis of COVID-19, RSV, and influenza infections.

Product typeAssay / Kit
Technology platformColloidal Gold
Application areaRespiratory Infections

Certificate

CE

Epidemiology

The illness known as COVID-19 (originally called novel coronavirus pneumonia in 2019) is a respiratory disease caused by the SARS-CoV-2 virus.

Respiratory syncytial virus (RSV) often causes upper and lower respiratory infections and is the primary cause of bronchiolitis and pneumonia in infants.

Influenza viruses are categorized into types A, B, C, and D based on antigenic differences in the nucleoprotein (NP) and matrix protein (M). Types A and B are the main human influenza pathogens, characterized by widespread epidemics and high infectivity, and they can lead to serious, life-threatening infections in children, the elderly, and people with weakened immune systems.

Work Flow

Acceptable specimen types:

  • Nasopharyngeal swab samples
  • Oropharyngeal swab sample
  • Nasal swab samples

Precautions: 1. Do not interpret results after 20 minutes. 2. Use the product within 1 hour of opening. 3. Add samples and buffers strictly per the instructions.

SKU codeAENE-RT152
Target regionSARS-CoV-2, Respiratory Syncytium, Influenza A&B Antigen
Storage temperature4-30 ℃ sealed and dry for storage
Sample typeNasopharyngeal swab、Oropharyngeal swab、Nasal swab
Shelf life24 months
Auxiliary instrumentsNot required
Extra ConsumablesNot required
Detection time15-20 mins
ApprovalOn request
DocumentsDatasheet, IFU, SDS, COA / conformance, origin, and export documents where available

FAQ

What should be confirmed before quotation?

Sample context, collection method, and extraction workflow should be confirmed before final kit selection.

Which documents can be requested?

Datasheet, IFU, SDS, COA / conformance, origin, insurance, and export documents can be checked where available.

Can the format be adjusted for different workflows?

Liquid or lyophilized format options should be confirmed together with instrument compatibility and shipment requirements.

Send the essentials for a useful first reply.

Share the application, sample type, format, destination, and expected quantity so AeneBio can route AENE-RT152 to the right quote or sample discussion.